Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer

NCT03981146 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT03981146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03981146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
Lead sponsor
University of Birmingham
Phase
Phase 2
Overall status
Completed
Start date
August 28, 2019
Completion date
November 26, 2024
Enrollment
35 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer